Search

Author/Creator van der Ark, Peter

1. A randomized Phase 2 study to evaluate the orexin-2 receptor antagonist seltorexant in individuals with insomnia without psychiatric comorbidity. (June 2018)

Authors:
De Boer, Peter; Drevets, Wayne C; Rofael, Hany; van der Ark, Peter; Kent, Justine M; Kezic, Iva; Parapatics, Silvia; Dorffner, Georg; van Gerven, Joop; Beneš, Heike; Keicher, Christian; Jahn, Holger; Seiden, David J; Luthringer, Remy
Journal:
Journal of psychopharmacology
Issue:
Volume 32:Number 6(2018)
Page Start:
668
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Fatty Acid Amide Hydrolase Inhibition by JNJ‐42165279: A Multiple‐Ascending Dose and a Positron Emission Tomography Study in Healthy Volunteers. Issue 4 (25th March 2018)

Authors:
Postnov, Andrey; Schmidt, Mark E.; Pemberton, Darrel J.; de Hoon, Jan; van Hecken, Anne; van den Boer, Maarten; Zannikos, Peter; van der Ark, Peter; Palmer, James A.; Rassnick, Stef; Celen, Sofie; Bormans, Guy; van Laere, Koen
Journal:
Clinical and translational science
Issue:
Volume 11:Issue 4(2018)
Page Start:
397
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. The selective orexin-2 receptor antagonist seltorexant improves sleep: An exploratory double-blind, placebo controlled, crossover study in antidepressant-treated major depressive disorder patients with persistent insomnia. (February 2019)

Authors:
Brooks, Sander; Jacobs, Gabriël E; de Boer, Peter; Kent, Justine M; Van Nueten, Luc; van Amerongen, Guido; Zuiker, Rob; Kezic, Iva; Luthringer, Remy; van der Ark, Peter; van Gerven, Joop MA; Drevets, Wayne
Journal:
Journal of psychopharmacology
Issue:
Volume 33:Number 2(2019)
Page Start:
202
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗